Ironwood Pharmaceuticals (IRWD) PT Trimmed at Wedbush on Positive Data from Competitor Synergy (SGYP)

June 17, 2015 12:27 PM

Wedbush analyst David Nierengarten reiterated a Neutral rating and lowered his price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $11.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found